Includes index.

Chapter 1. Using Facebook, Twitter, and LinkedIn to Explain VC Valuation Gains and Losses: How VCs, Angels, Founders, and Employees Give Up Investment Cash Flow Every Day -- Chapter 2. Should Venture-Backed Companies Even Consider a DCF Model? Introducing the Life Science Valuation Case: Zogenix -- Chapter 3. Valuation Methods versus Allocation Methods Regarding Zogenix -- Chapter 4. Applying the Typical DCF Model to a Venture-Backed Company Hardly Ever Works -- Chapter 5. "Enterprise Value" + "Allocation Methods" = Value Destruction: Undervaluing Companies and Overvaluing Employee Options -- Chapter 6. Why You Should D.O.W.T. (Doubt) Venture Capital Returns--Option Pool Reserve -- Chapter 7. If Valuation Can't Make You Money, Do You Really Need It?: Learning Practical Applications from Kayak.com -- Chapter 8. Don't Hate the Appraiser (Blame the Auditor Instead) -- Chapter 9. Don't Blame the Auditors (Blame the Practice Aid Instead): 409A Valuation Professionals Discussing Topic 820 (FAS 157) With VC CFOs -- Chapter 10. Now That You Understand Venture Capital Valuation, Share It.

"Very few of the decision makers involved in a venture backed company have a definitive understanding of how valuation techniques are being applied to their financial statements and their decision making process. This casebook provides a quick and accurate road map on how valuation techniques used for tax, financial reporting and deal structure impact a company's past, present and future. The book includes real world case studies to simplify this complex subject for the practitioners serving companies, the founders and executives running the companies, and the investors that fund the companies"-- Provided by publisher.